Sinovac Biotech Co., Ltd clinical trials

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company

The registry lists 163 studies whose lead sponsor is Sinovac Biotech Co., Ltd or one of 5 companies grouped under it. 37 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.

Keep track of what changes. Save the Sinovac Biotech Co., Ltd studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed: 105
Recruiting: 17
Not yet recruiting: 17
Status unknown: 10
Active, not recruiting: 6
Withdrawn: 3

Phase

Phase 4: 57
Phase 3: 47
Phase 1: 27
Phase 2: 22

Where

China: 137
Philippines: 6
Pakistan: 4
Vietnam: 3
Chile: 2
Turkey: 2

Focus areas

Conditions Sinovac Biotech Co., Ltd leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

COVID-1930 Influenza, Human25 Hand, Foot and Mouth Disease20 Chickenpox17 Herpes Zoster16 Poliomyelitis15 Mouth Diseases14 Pneumococcal Infections13 Foot-and-Mouth Disease12

Studies

Recruiting first, then most recently updated. Showing 50 of 163. Browse all 163 →

Sinovac Biotech Co., Ltd clinical trials

Status

Phase

Where

Registry sponsor names on this page

Focus areas

Studies